%D8%B1%D9%8A%D9%85%D8%AF%D9%8A%D8%B3%D9%8A%D9%81%D9%8A%D8%B1%E0%A6%B0%E0%A7%87%E0%A6%AE%E0%A6%A1%E0%A7%87%E0%A6%B8%E0%A6%BF%E0%A6%AD%E0%A6%BF%E0%A6%B0RemdesivirCategory:RemdesivirRemdesivirRemdesivirRemdesivirRemdesivirRemdesivirRemdesivir%D8%B1%D9%85%D8%AF%D8%B3%DB%8C%D9%88%DB%8C%D8%B1RemdesiviiriRemd%C3%A9sivir%D7%A8%D7%9E%D7%93%D7%A1%D7%99%D7%91%D7%99%D7%A8Remdesivir%D5%8C%D5%A5%D5%B4%D5%A4%D5%A5%D5%BD%D5%AB%D5%BE%D5%AB%D6%80RemdesivirRemdesivirRemdesivir%E3%83%AC%E3%83%A0%E3%83%87%E3%82%B7%E3%83%93%E3%83%AB%E1%83%A0%E1%83%94%E1%83%9B%E1%83%93%E1%83%94%E1%83%A1%E1%83%98%E1%83%95%E1%83%98%E1%83%A0%E1%83%98%EB%A0%98%EB%8D%B0%EC%8B%9C%EB%B9%84%EB%A5%B4Remdesiviras%E0%B4%B1%E0%B5%86%E0%B4%82%E0%B4%A1%E0%B5%86%E0%B4%B8%E0%B4%BF%E0%B4%B5%E0%B4%BF%E0%B5%BCRemdesivirRemdesivirRemdesivirRemdesiwirRemdesivirRemdesivir%D0%9A%D0%B0%D1%82%D0%B5%D0%B3%D0%BE%D1%80%D0%B8%D1%8F:%D0%A0%D0%B5%D0%BC%D0%B4%D0%B5%D1%81%D0%B8%D0%B2%D0%B8%D1%80%D0%A0%D0%B5%D0%BC%D0%B4%D0%B5%D1%81%D0%B8%D0%B2%D0%B8%D1%80RemdesivirRemdesivirRemdesivirRemdesivir%D8%B1%DB%90%D9%85%D8%AF%DB%90%D8%B3%D9%89%DB%8B%D9%89%D8%B1(%DB%8B%D8%A7%D9%83%D8%B3%D9%89%D9%86)%D0%A0%D0%B5%D0%BC%D0%B4%D0%B5%D1%81%D0%B8%D0%B2%D1%96%D1%80Remdesivir%E7%91%9E%E5%BE%B7%E8%A5%BF%E9%9F%A6
about
P2176
Mild/Moderate 2019-nCoV Remdesivir RCTSevere 2019-nCoV Remdesivir RCTStudy to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19)Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment
P4844
Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys.Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses.Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses.GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses.Broad-spectrum Investigational Agent GS-5734 for the Treatment of Ebola, MERS Coronavirus and Other Pathogenic Viral Infections with High Outbreak Potential.Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease.Mechanism of Inhibition of Ebola Virus RNA-Dependent RNA Polymerase by RemdesivirGS-5734 to Assess the Antiviral Activity, Longer-Term Clearance of Ebola Virus, and Safety in Male Ebola Survivors With Evidence of Ebola Virus Persistence in SemenFirst Case of 2019 Novel Coronavirus in the United StatesBroad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymeraseRemdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitroSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challengesProphylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infectionExpanded Access Remdesivir (RDV; GS-5734™)Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoVAdaptive COVID-19 Treatment Trial (ACTT) – et randomiseret studie af behandling af indlagte patienter med COVID-19 i EuropaExpanded Access Treatment Protocol: Remdesivir (RDV; GS-5734) for the Treatment of SARS-CoV2 (CoV) InfectionCurrent knowledge about the antivirals remdesivir (GS-5734) and GS-441524 as therapeutic options for coronavirusesThe antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirusRemdesivir as a possible therapeutic option for the COVID-19Arguments in favour of remdesivir for treating SARS-CoV-2 infectionsRemdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitroRibavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking studyRemdesivir attenuates high fat diet (HFD)-induced NAFLD by regulating hepatocyte dyslipidemia and inflammation via the suppression of STING[Remdesivir, the antiviral hope against SARS-CoV-2]Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidenceCompassionate Use of Remdesivir for Patients with Severe Covid-19Delayed Initiation of Remdesivir in a COVID-19 Positive PatientRemdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sitesRemdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potencyEfficacy of remdesivir in a rhesus macaque model of MERS-CoV infectionEfficacy of remdesivir versus placebo for the treatment of COVID-19: A protocol for systematic review and meta-analysis of randomized controlled trialsRemdesivir (GS-5734) protects African green monkeys from Nipah virus challengeRemdesivir in covid-19[Remdesivir for patients with severe COVID-19]Remdesivir potently inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in miceRemdesivir for the Treatment of Covid-19 - Preliminary Report
P921
description
antiviralt läkemedel
@sv
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de-ch
chemische verbinding
@nl
component quimic
@oc
name
Remdesivir
@da
Remdesivir
@de
Remdesivir
@eu
Remdesivir
@hu
Remdesivir
@id
Remdesivir
@is
Remdesivir
@it
Remdesivir
@ms
Remdesivir
@my
Remdesivir
@nl
label
Remdesivir
@da
Remdesivir
@de
Remdesivir
@eu
Remdesivir
@hu
Remdesivir
@id
Remdesivir
@is
Remdesivir
@it
Remdesivir
@ms
Remdesivir
@my
Remdesivir
@nl
altLabel
2-ethylbutyl (2S)-2-({[(2R,3S, ...... oxyphosphoryl}amino)propanoate
@en
GS-5734
@cs
GS-5734
@da
GS-5734
@en
GS-5734
@ko
Remdesivir
@cs
prefLabel
Remdesivir
@da
Remdesivir
@de
Remdesivir
@eu
Remdesivir
@hu
Remdesivir
@id
Remdesivir
@is
Remdesivir
@it
Remdesivir
@ms
Remdesivir
@my
Remdesivir
@nl
P31
P661
P662
P665
P117
P178
P1909
P2017
CCC(CC)COC(=O)[C@H](C)N[P@](=O ...... =C3N2N=CN=C3N)O)O)OC4=CC=CC=C4
P2067
P231
1809249-37-3
P233
Nc3ncnn2c3ccc2C(C#N)(C1O)OC(C1O)CO[P](=O)(NC(C)C(=O)OCC(CC)CC)Oc4ccccc4
P234
1S/C27H35N6O8P/c1-4-18(5-2)13- ...... t17-,21+,23+,24+,27-,42-/m0/s1
P235
RWWYLEGWBNMMLJ-YSOARWBDSA-N
P274
C₂₇H₃₅N₆O₈P
P3345
P366
P373
Remdesivir